Apontis Pharma
Manufacturing · Germany · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Alfred-nobel-str. 10, Monheim am Rhein, ...Phone Number
+49 217389554949Website
www.apontis-pharma.deRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Apontis Pharma
APONTIS PHARMA is a Single Pill Company that aims to connect various stakeholders in the healthcare sector to enhance medical, economic, and ecological progress. Their products focus on providing optimal care for patients, ultimately improving their quality of life. The company is committed to good corporate governance and values the interests of both patients and investors. APONTIS PHARMA seeks to build bridges in healthcare, ensuring that all parties benefit from their innovations.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Apontis Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Apontis Pharma
Product Launch: Get notified when Apontis Pharma launches new products
Earning: See what the market has to say on Apontis Pharma recently announced quarterly report
Apontis Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Apontis Pharma has new funding data
Check if Apontis Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Apontis Pharma is spiking on competitors!
Click to see if Apontis Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Apontis Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Apontis Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Apontis Pharma.
Apontis Pharma Tech Stack
A closer look at the technologies used by Apontis Pharma
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Open Position
Apontis Pharma News & Media
Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG
FRANKFURT, Germany, Dec. 9, 2024 /PRNewswire/ -- Zentiva AG, a wholly-owned subsidiary of Zentiva Pharma GmbH, headquartered in Frankfurt am Main, Germany, and part of Zentiva group ("Zentiva"), completed the voluntary public purchase offer for the shares of APONTIS PHARMA AG ("APONTIS...Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer
FRANKFURT, Germany, Nov. 26, 2024 /PRNewswire/ -- Zentiva AG, a wholly-owned subsidiary of Zentiva Pharma GmbH, headquartered in Frankfurt am Main, Germany, and part of Zentiva group ("Zentiva"), announced today that it has secured approx. 83.57% of the share capital and approx. 85.27% of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Apontis Pharma
Sign Up For FreeTo access detailed company insights
APONTIS PHARMA is a Single Pill Company that aims to connect various stakeholders in the healthcare sector to enhance medical, economic, and ecological progress. Their products focus on providing optimal care for patients, ultimately improving their quality of life. The company is committed to good corporate governance and values the interests of b... Read More
